Genes in the RB pathway and their knockout in mice

Seminars in Cancer Biology

Volumn 7, Issue 5, 1996, Pages 279-289

  Lin, Suh Chin J ^a   Skapek, Stephen X ^a,b   Lee, Eva Y H P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Cell cycle regulators; Gene knockout; RB; Tumor suppressor genes

Indexed keywords

REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCHEMISTRY; CELL CYCLE; CELL SPECIFICITY; GENE TECHNOLOGY; MOUSE; NONHUMAN; RETINOBLASTOMA; REVIEW; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

EID: 0030265327     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0036     Document Type: Review

References (73)

1. 1. Riley DJ, Lee EY-HP, Lee W-H (1994) The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol 10:1-29
2. 2. Du W, Vidal M, Xie J-E, Dyson N (1996) RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes and Dev 10:1206-1218
3. 3. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
4. 4. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330
5. 5. Nevins JR (1992) E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429
6. 6. Muller R, Mumberg D, Lucibello FC (1993) Signals and genes in the control of cell-cycle progression. [Review]. Biochim Biophys Acta 1155:151-179
7. 7. Claudio PP, Howard CM, Baldi A, Luca AD, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A (1994) p130/ pRb2 has grown suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54:5556-5560
8. 8. Zu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston DM, Dyson N, Harlow E (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7:1111-1125
9. 9. Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E (1995) The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/ cdk complexes. EMBO J 14:1904-1913
10. 10. Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E (1995) The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/ cdk complexes. EMBO J 14:1904-1913
11. 11. Lam EW, La TN (1994) DP and E2F proteins: coordinating transcription with cell cycle progression. [Review]. Curr Opin Cell Biol 6:859-866
12. 12. Clarke AR, Maandag ER, van Roon M, van der Lugt NMT, van der Valk M, Hooper ML, Berns A, te Riele H (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330
13. 13. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359:295-300
14. 14. Lee EY-HP, Chang C-X, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A (1992) Mice deficient for Rb are non viable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294
15. 15. Lee EY-HP, Hu N, Yuan S-SF, Cox LA, Bradley A, Lee W-H, Herrup K (1994) Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 8:2008-2021
16. 16. Harrison DJ, Hooper ML, Armstrong JF, Clarke AR (1995) Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10:1615-1620
17. 1-/+ mice are predisposed to tumors of the pituitary gland with nearly complete penetrance. Oncogene 9:1021-1027
18. 18. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal GB (1994) Reversal of terminal differentiation mediated by p107 in Rb-/ -muscle cells. Science 264:1467-1471
19. 19. Chen G, Guy CT, Chen H-W, Hu N, Lee EY-HP, Lee W-H (1996) Molecular cloning and developmental expression of mouse p130, a member of the retinoblastoma gene family. J Biol Chem 271:9567-9572
20. 20. Cobrinik D, Lee M-H, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T (1996) Shared role in the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644
21. 21. Lee M-H, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T (1996) Targeted disruption of p107: functional overlap of p107 and RB. Genes Dev 10:1621-1632
22. 22. Maandag ECR, Valk Mvd, Vlaar M, Feltkamp C, O'Brien J, Roon MV, Lugt NVD, Berns A, Riele HT (1994) Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 13:4260-4268
23. 23. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T (1994) Extensive contribution of Rb-deficient cells in chimeric mice with limited histopathologic consequences. EMBO J 13:4251-4259
24. 24. Sherr C (1993) Mammalian G1 cyclins. Cell 73:1059-1065
25. 25. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671
26. 26. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124-2130
27. 27. Lovec H, Grzeschiczek A, Kowalski MB, Moroy T (1994) Cyclin D1/ bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13:3487-3495
28. 28. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630
29. 29. Li R, Waga S, Hannon GJ, Beach D, Stillman B (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537
30. 30. Pan ZQ, Reardon JT, Li L, Flores RH, Legerski R, Sancar A, Hurwitz J (1995) Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J Biol Chem 270:22008-22016
31. 31. Umar A, Buermeyer AB, Simon JA, Thomas DC, Clark AB, Liskay RM, Kunkel TA (1996) Requirement of PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87:65-73
32. 32. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van DT (1996) Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev 10:245-260
33. 33. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/ WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684
34. 34. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356:215-221
35. 35. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen [see comments]. Science 266:1376-1380
36. 36. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL, Ross AH (1996) The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Molec Cell Biol 16:1335-1341
37. 37. Wang J, Walsh K (1996) Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation. Science 273:359-361
38. KIP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66
39. 39. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744
40. 40. Kiyokawa H, Kineman RD, Manova TK, Scares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732
41. 41. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retina dysplasia, and pituitary tumors. Cell 85:707-720
42. 42. Bignon YJ, Chen Y, Chang C-Y, Riley DJ, Windle JJ, Mellon PL, Lee W-H (1993) Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev 7:1654-1662
43. 43. Coats S, Flanagan WM, Nourse J, Roberts JM (1996) Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880
44. 44. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662
45. 45. Matsuoka S, Thompson JS, Edwards MC, Bartlettta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ, Feinberg AP (1996) Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Nat Acad Sci USA 93:3026-3030
46. kip2 is mutated in Beckwith-Wiedemann syndrome. Nature Genet 14:171-173
47. 47. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000
48. 48. Otterson GA, Kratzke RA, Coxon A, Kim YW, Kaye FJ (1994) Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378
49. 49. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho RA (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37
50. 50. Guy CT, Zhou W, Kaufman S, Robinson MO (1996) E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Molec Cell Biol 16:685-693
51. 51. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WJ, Livingston DM, Orkin SH, Greenberg ME (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-561
52. 52. Yimasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537-548
53. 53. Zwicker J, Liu N, Engeland K, Lucibello FC, Muller R (1996) Cell cycle regulation of E2F site occupancy in vivo. Science 271:1595-1597
54. 54. Shi Y, Seto E, Chang LS, Shenk T (1991) Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67:377-388
55. 55. Wu CL, Classon M, Dyson N, Harlow E (1996) Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Molec Cell Biol 16:3698-3706
56. 56. Dynlacht BD, Brook A, Dembski M, Yenush L, Dyson N (1994) DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. Proc Nat Acad Sci USA 91:6359-6363
57. 57. Ohtani K, Nevins JR (1994) Functional properties of a Drosophila homolog of the E2F1 gene. Mol Cell Biol 14:1603-1612
58. 58. Duronio RJ, O'Farrell PH, Xie J-E, Brook A, Dyson N (1995) The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev. 9:1445-1455
59. 59. Almasan A, Yin Y, Kelly RE, Lee EY-HP, Bradley A, Li W, Bertino JR, Wahl GM (1995) Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F responsive genes, and apoptosis. Proc Nat Acad Sci USA 92:5436-5440
60. 60. Herrera RE, Sah VP, Williams BO, Makela TM, Weinberg RA, Jacks T (1996) Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in RB-deficient fibroblasts. Molec Cell Biol 16:2402-2407
61. 61. Goodman CS, Shatz CJ (1993) Developmental mechanisms that generate precise patterns of neuronal connectivity. [Review]. Cell 72(S):77-98
62. 62. Morgenbesser SD, Williams BO, Jacks T, DePinho RA (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74
63. 63. Pan H, Griep AE (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 8:1285-1299
64. 64. Howes KA, Ranson N, Papermaster DS, Lasudry JGH, Albert DM, Windle JL (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8:1300-1310
65. 65. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T (1994) Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484
66. 66. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324
67. 67. Chen J, Lansford R, Stewart V, Young F, Alt FW (1993) RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc Nat Acad Sci USA 90:4528-4532
68. 68. Rossant J, Nagy A (1995) Genome engineering: the new mouse genetics. [Review]. Nature Medicine 1:592-594
69. 69. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. [Review]. Cell 61:759-767
70. +/- mice. Genes Dev 10:1870-1879
71. 71. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, Hennighausen L (1996) Time-sensitive reversal of hyperplasia in transgenic mice expressing SV 40 T antigen. Science 273:1384-1386
72. 72. Harvey M, Vogel H, Lee EY-HP, Bradley A, Donehower LA (1995) Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151
73. 73. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi Y-P, Pinkel D, Grey J, Bradley A, Medina D, Varmus HE (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promote chromosomal instability. Genes Dev 9:882-895